News Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Delayed Nyse Other stock markets 03:57:20 2024-04-19 pm EDT			5-day change	1st Jan Change
85.86 ^USD	-0.68%		-4.84%	+12.67%

Apr. 17	Baird Adjusts Edwards Lifesciences Price Target to $102 From $100	MT
Apr. 17	Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024	Apr. 18	BU
Baird Adjusts Edwards Lifesciences Price Target to $102 From $100	Apr. 17	MT
Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating	Apr. 17	MT
Market sentiment sours	Apr. 16
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	Apr. 16
Zacks Investment Research Adjusts Price Target on Edwards Lifesciences to $95 From $97	Apr. 15	MT
Truist Securities Adjusts Edwards Lifesciences Price Target to $105 From $97, Buy Rating Kept	Apr. 15	MT
RBC Raises Price Target on Edwards Lifesciences to $101 From $95, Keeps Outperform Rating	Apr. 15	MT
Mizuho Securities Adjusts Price Target on Edwards Lifesciences to $105 From $95, Maintains Buy Rating	Apr. 11	MT
Edwards Lifesciences Insider Sold Shares Worth $1,154,142, According to a Recent SEC Filing	Apr. 08	MT
Edwards Lifesciences Insider Sold Shares Worth $1,329,472, According to a Recent SEC Filing	Apr. 08	MT
Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It	Apr. 08	AQ
Edwards Lifesciences Announces the Release of Data from the Hudle Study	Apr. 07	CI
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It	Apr. 07	BU
Edwards Lifesciences Insider Sold Shares Worth $2,712,418, According to a Recent SEC Filing	Apr. 05	MT
Citigroup Raises Price Target on Edwards Lifesciences to $98 From $90, Maintains Neutral Rating	Apr. 03	MT
Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1)	Apr. 03	AQ
Edwards Lifesciences Insider Sold Shares Worth $688,423, According to a Recent SEC Filing	Apr. 02	MT
North American Morning Briefing : Stocks Edge -2-	Mar. 27	DJ
Edwards Lifesciences Longtime Chair To Retire	Mar. 26	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Summary

Filters